Arca
Skip to content
Tools
Tools

RXiBreeze PAP System (RXiBreeze 20C)

Ventilator, Non-Continuous (Respirator). 510(k) K253044, from Resvent Medical Technology Co., Ltd. (Shenzhen, CN). Product code BZD, class 2.

As of Nov 18, 2026, K253044 is an FDA 510(k) held by Resvent Medical Technology Co., Ltd., substantially equivalent on Jul 23, 2026 after 304 days, with no recalls tied to it in FDA's recall database.

  • Review time: 304 days
  • Recalls: 0

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The RXiBreeze™ PAP system delivers positive airway pressure therapy for the treatment of obstructive sleep apnea in spontaneously breathing adult patients. It is for single patient use in the home, hospital, or institutional environment.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other BZD clearances

The newest 510(k)s for the same product code; their median review was 215 days; see every BZD device

Record

Type
Traditional
Received
Sep 22, 2025
Review panel
Anesthesiology
Regulation
21 CFR 868.5905

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.